已收盤 02-06 16:00:00 美东时间
+0.002
+0.81%
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $191.000 thousand
2025-11-17 21:38
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326205/000118518525001326/igc8k100125.htm
2025-10-02 04:46
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $4.5.
2025-08-26 18:07
Igc Pharma, Inc. (IGC) has disclosed a new risk, in the Debt & Financing ca...
2025-08-16 14:01
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 20 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same
2025-08-15 04:13
Rebounding from a recent dip to $0.32, IGC Pharma's stock surged 69.4% to $0.62 on Wednesday, in after-hours trading.
2025-07-10 11:11
India Globalization Capital ( ($IGC) ) has released its Q4 earnings. Here is a ...
2025-07-01 11:50
Today, several major companies are expected to report earnings: IGC Pharma (IGC...
2025-06-30 19:05
IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period
2025-06-28 05:59
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1105190809351499777.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• RBC Capital:维持Canadian Natural Res(CNQ)"跑赢大市"评级,目标价从62美元升至63美元</p> <p>• 摩根大通:维持Carvana(CVNA)"超配"评级,目标价从350美元升至3
2025-03-10 10:29